Cargando…

The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases

Tauroursodeoxycholic acid (TUDCA) is the taurine conjugate of ursodeoxycholic acid (UDCA), a US Food and Drug Administration–approved hydrophilic bile acid for the treatment of certain cholestatic liver diseases. There is a growing body of research on the mechanism(s) of TUDCA and its potential ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vang, Sheila, Longley, Katie, Steer, Clifford J., Low, Walter C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Advances in Health and Medicine 2014
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030606/ https://www.ncbi.nlm.nih.gov/pubmed/24891994 http://dx.doi.org/10.7453/gahmj.2014.017

Ejemplares similares

Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease
por: Daruich, Alejandra, et al.
Publicado: (2019)

Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models
por: Daruich, Alejandra, et al.
Publicado: (2022)

Urso, Der Letzte Des Hochsalerno, Arzt, Philosoph, Theologe
por: Riesman, David
Publicado: (1935)

Prevention of Acute Kidney Injury by Tauroursodeoxycholic Acid in Rat and Cell Culture Models
por: Gupta, Sandeep, et al.
Publicado: (2012)

Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis
por: Ahn, Tae-Keun, et al.
Publicado: (2020)

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
por: Elia, A. E., et al.
Publicado: (2015)

Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
por: Reggiardo, Giorgio, et al.
Publicado: (2023)

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
por: Khalaf, Kareem, et al.
Publicado: (2022)

Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis
por: Pike, Colleen M., et al.
Publicado: (2022)

Effect of Tauroursodeoxycholic Acid on Inflammation after Ocular Alkali Burn
por: Huang, Yanqiao, et al.
Publicado: (2022)

Mechanisms of tauroursodeoxycholate-mediated inhibition of apoptosis
por: Sommerfeld, Annika, et al.
Publicado: (2014)

Ursodeoxycholic Acid but Not Tauroursodeoxycholic Acid Inhibits Proliferation and Differentiation of Human Subcutaneous Adipocytes
por: Mališová, Lucia, et al.
Publicado: (2013)

Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
por: Kars, Marleen, et al.
Publicado: (2010)

Tauroursodeoxycholic acid: more than just a neuroprotective bile conjugate
por: Romero-Ramírez, Lorenzo, et al.
Publicado: (2017)

Metabolomics and Lipidomics Study Unveils the Impact of Tauroursodeoxycholic Acid on Hyperlipidemic Mice
por: Cui, Na, et al.
Publicado: (2023)

Treatment of in vitro-Matured Bovine Oocytes With Tauroursodeoxycholic Acid Modulates the Oxidative Stress Signaling Pathway
por: Pioltine, Elisa Mariano, et al.
Publicado: (2021)

Tauroursodeoxycholic acid attenuates endoplasmic reticulum stress and protects the liver from chronic intermittent hypoxia induced injury
por: Hou, Yanpeng, et al.
Publicado: (2017)

Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation
por: Yanguas-Casás, Natalia, et al.
Publicado: (2014)

Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury
por: Guo, Honglei, et al.
Publicado: (2016)

Tauroursodeoxycholic acid mediates endoplasmic reticulum stress and autophagy in adrenocortical carcinoma cells
por: Huang, Xuemei, et al.
Publicado: (2019)

Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives
por: Kusaczuk, Magdalena
Publicado: (2019)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases
por: Mahgoub, Amar, et al.
Publicado: (2016)

Tauroursodeoxycholic acid reduces ER stress by regulating of Akt-dependent cellular prion protein
por: Yoon, Yeo Min, et al.
Publicado: (2016)

Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation
por: Sun, Dongdong, et al.
Publicado: (2017)

The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases
por: Moscoso, Carlos G., et al.
Publicado: (2020)

Polyhexamethyleneguanidine Phosphate-Induced Cytotoxicity in Liver Cells Is Alleviated by Tauroursodeoxycholic Acid (TUDCA) via a Reduction in Endoplasmic Reticulum Stress
por: Kim, Sou Hyun, et al.
Publicado: (2019)

Optimizing treatment of tauroursodeoxycholic acid to improve embryonic development after in vitro maturation of cumulus-free oocytes in mice
por: Mochizuki, Masato, et al.
Publicado: (2018)

Effects of Tauroursodeoxycholic Acid and 4-Phenylbutyric Acid on Selenium Distribution in Mice Model with Type 1 Diabetes
por: Xing, Dongyang, et al.
Publicado: (2022)

Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment
por: Mantopoulos, Dimosthenis, et al.
Publicado: (2011)

Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2015)

Tauroursodeoxycholic Acid Attenuates Renal Tubular Injury in a Mouse Model of Type 2 Diabetes
por: Zhang, Jing, et al.
Publicado: (2016)

Discovery of tauroursodeoxycholic acid biotransformation enzymes from the gut microbiome of black bears using metagenomics
por: Song, Can, et al.
Publicado: (2017)

Tauroursodeoxycholic Acid Decreases Keloid Formation by Reducing Endoplasmic Reticulum Stress as Implicated in the Pathogenesis of Keloid
por: Kim, Sunje, et al.
Publicado: (2021)

Tauroursodeoxycholic Acid Protects Retinal and Visual Function in a Mouse Model of Type 1 Diabetes
por: Fu, Jieming, et al.
Publicado: (2021)

Tauroursodeoxycholic Acid (TUDCA)—Lipid Interactions and Antioxidant Properties of TUDCA Studied in Model of Photoreceptor Membranes
por: Sabat, Michał J., et al.
Publicado: (2021)

Tauroursodeoxycholic acid functions as a critical effector mediating insulin sensitization of metformin in obese mice
por: Zhang, Ya, et al.
Publicado: (2022)

Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex
por: Feng, Rui, et al.
Publicado: (2018)

The Effect of Tauroursodeoxycholic Acid (TUDCA) Treatment on Pregnancy Outcomes and Vascular Function in a Rat Model of Advanced Maternal Age
por: Pasha, Mazhar, et al.
Publicado: (2022)

Effect of Tauroursodeoxycholic Acid and 4-Phenylbutyric Acid on Metabolism of Copper and Zinc in Type 1 Diabetic Mice Model
por: Zhou, Qi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5gm6p2nou2dntfdv6cb3kfr93r